Could cause temporary or reversible harm; serious harm is unlikely.
CGMP Deviations: Various strengths of ibuprofen tablets/caplets are being recalled due to complaints of odor related to CGMP deficiencies.
| Brand name | IBUPROFEN |
| Generic name | IBUPROFEN |
| Active ingredient(s) | IBUPROFEN |
| Distributed by / for | Time Caps Labs, Farmingdale, NY |
| NDC | 49483-603-01 |
| Full product label | Ibuprofen Tablets USP 600 mg, a) 100 tablet (NDC 49483-603-01) and b) 500 tablet bottles (NDC 49483-603-50), Rx, Manufactured for: Time Caps Labs, Farmingdale, NY, Manufactured by: Marksans Pharma, Ltd., Plot No. L-82, L-83 Verna indl. Estate Verna, Goa-403 722, India |
| Recalling firm | Time-Cap Laboratories, Inc. |
| Distribution | Nationwide. |
| Quantity | N/A |
| Recall initiated | 2018-01-11 |
| Report date | 2018-05-02 |
| Recall completed | 2021-01-20 |
| Recall number | D-0689-2018 |
| Classification | Class II |
| FDA status | Terminated |
| Origin on file | Farmingdale NY United States |
Source: U.S. FDA enforcement database (openFDA). Look this up on the official FDA recalls site ↗